One-Year Outcome of Multiple Blood–Brain Barrier Disruptions With Temozolomide for the Treatment of Glioblastoma

Introduction: To overcome the blood–brain barrier (BBB) which interferes with the effect of chemotherapeutic agents, we performed multiple disruptions of BBB (BBBD) with magnetic resonance-guided focused ultrasound on patients with glioblastoma (GBM) during standard adjuvant temozolomide (TMZ) chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, So Hee, Kim, Myung Ji, Jung, Hyun Ho, Chang, Won Seok, Choi, Hyun Seok, Rachmilevitch, Itay, Zadicario, Eyal, Chang, Jin Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511634/
https://www.ncbi.nlm.nih.gov/pubmed/33014832
http://dx.doi.org/10.3389/fonc.2020.01663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511634/
https://www.ncbi.nlm.nih.gov/pubmed/33014832
http://dx.doi.org/10.3389/fonc.2020.01663

Ejemplares similares